Scotiabank Cuts Oracle (NYSE:ORCL) Price Target to $220.00

Posted by James Conley on Feb 6th, 2026

Oracle (NYSE:ORCL – Free Report) had its price target lowered by Scotiabank from $260.00 to $220.00 in a research report report published on Tuesday, MarketBeat Ratings reports. Scotiabank currently has a sector outperform rating on the enterprise software provider’s stock.

ORCL has been the subject of several other research reports. Royal Bank Of Canada reaffirmed a “sector perform” rating on shares of Oracle in a research note on Monday. William Blair reaffirmed an “outperform” rating on shares of Oracle in a research report on Friday, October 17th. Mizuho set a $400.00 price target on Oracle in a research report on Monday, December 15th. Sanford C. Bernstein lowered their price objective on Oracle from $364.00 to $339.00 and set an “outperform” rating for the company in a research report on Thursday, December 11th. Finally, Robert W. Baird lowered their price target on shares of Oracle from $365.00 to $315.00 and set an “outperform” rating for the company in a report on Tuesday, November 18th. Three analysts have rated the stock with a Strong Buy rating, twenty-six have given a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Oracle currently has a consensus rating of “Moderate Buy” and a consensus price target of $295.72.

Check Out Our Latest Stock Report on ORCL

Oracle Stock Performance

NYSE ORCL opened at $136.37 on Tuesday. The firm has a 50-day moving average price of $189.93 and a two-hundred day moving average price of $234.83. Oracle has a 12-month low of $118.86 and a 12-month high of $345.72. The company has a market capitalization of $391.81 billion, a P/E ratio of 25.63, a P/E/G ratio of 1.28 and a beta of 1.64. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 3.28.

Oracle (NYSE:ORCL – Get Free Report) last released its earnings results on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.62. Oracle had a return on equity of 70.60% and a net margin of 25.28%.The firm had revenue of $16.06 billion during the quarter, compared to the consensus estimate of $16.19 billion. During the same period in the prior year, the company posted $1.47 EPS. The company’s revenue was up 14.2% compared to the same quarter last year. Analysts anticipate that Oracle will post 5 earnings per share for the current year.

Oracle Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 23rd. Stockholders of record on Friday, January 9th were paid a $0.50 dividend. The ex-dividend date of this dividend was Friday, January 9th. This represents a $2.00 annualized dividend and a dividend yield of 1.5%. Oracle’s dividend payout ratio is 37.59%.

Insider Buying and Selling

In other news, Director Naomi O. Seligman sold 2,223 shares of the company’s stock in a transaction on Tuesday, December 23rd. The shares were sold at an average price of $196.61, for a total value of $437,064.03. Following the completion of the sale, the director owned 25,596 shares in the company, valued at $5,032,429.56. This represents a 7.99% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Douglas A. Kehring sold 35,000 shares of the company’s stock in a transaction dated Thursday, January 15th. The stock was sold at an average price of $194.89, for a total transaction of $6,821,150.00. Following the completion of the sale, the executive vice president directly owned 33,638 shares of the company’s stock, valued at $6,555,709.82. The trade was a 50.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 62,223 shares of company stock worth $12,136,764. 40.90% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Oracle

Several institutional investors have recently added to or reduced their stakes in ORCL. Swiss National Bank raised its holdings in Oracle by 7.6% in the 2nd quarter. Swiss National Bank now owns 5,093,200 shares of the enterprise software provider’s stock worth $1,113,526,000 after purchasing an additional 360,000 shares during the period. Patton Fund Management Inc. increased its position in Oracle by 626.1% in the third quarter. Patton Fund Management Inc. now owns 11,537 shares of the enterprise software provider’s stock worth $3,245,000 after buying an additional 9,948 shares in the last quarter. Private Wealth Asset Management LLC raised its stake in shares of Oracle by 9.2% in the second quarter. Private Wealth Asset Management LLC now owns 3,817 shares of the enterprise software provider’s stock worth $835,000 after buying an additional 321 shares during the period. Soltis Investment Advisors LLC lifted its position in shares of Oracle by 4.8% during the 2nd quarter. Soltis Investment Advisors LLC now owns 32,937 shares of the enterprise software provider’s stock valued at $7,201,000 after buying an additional 1,515 shares in the last quarter. Finally, Cascade Investment Group Inc. bought a new position in shares of Oracle during the 2nd quarter valued at approximately $239,000. 42.44% of the stock is owned by hedge funds and other institutional investors.

Oracle News Roundup

Here are the key news stories impacting Oracle this week:

Positive Sentiment: Oracle posted a recent quarterly beat (EPS above consensus and ~14% revenue growth) and still shows a large services/backlog that supports cloud growth — a fundamental positive for long-term investors.
Positive Sentiment: Record bond sale / debt funding helped calm credit markets and could smooth financing for Oracle’s AI center plans. TipRanks: Why Oracle’s Record Bond Sale Clears the Way for More AI Debt
Positive Sentiment: New commercial wins: multiple Canadian healthcare organizations selected Oracle Health’s Clinical AI Agent for a pilot — evidence of enterprise demand for Oracle’s AI offerings. PR Newswire: Multiple Canadian Healthcare Organizations Select Oracle Health Clinical AI Agent
Neutral Sentiment: Equity/debt issuance activity: Oracle has multiple financing vehicles active (equity distribution agreement, Series D mandatory convertible preferred, senior notes and planned large equity sale) — this provides capital but timing/structure will determine dilution vs. benefit. TipRanks: Oracle Issues Series D Mandatory Convertible Preferred Stock
Neutral Sentiment: Analyst views remain mixed: some firms trimmed targets (BMO, Scotiabank, others) while many continue to rate ORCL a buy — the selloff has pushed valuations lower and widened the gap in analyst targets and scenarios.
Negative Sentiment: Big AI funding plan: Oracle’s announced $45–50 billion AI infrastructure capital plan (equity + debt + other instruments) is the primary driver of the drop — investors worry about dilution from the equity component, incremental leverage and execution/timing risk. Yahoo Finance: Oracle Is Down After Unveiling AI Infrastructure Capital Plan
Negative Sentiment: Multiple class-action and bondholder lawsuits announced alleging securities issues tied to Oracle disclosures and its debt/offering documents — legal risk can amplify short-term selling and add unknown costs. GlobeNewswire: ORCL Class Action Alert (Robbins LLP) BusinessWire: Howard G. Smith Class Action Notice
Negative Sentiment: Funding/project risks: reports that banks are trying to offload data-center loans and a Michigan AG request to revisit utility approval for an Oracle/OpenAI data center raise execution and permitting concerns. TipRanks: Banks Explore Selling Data Center Loans Financial Post: Michigan AG Urges Revisit on Data Center Power Plan
Negative Sentiment: Market positioning and flows: unusually heavy put buying and elevated trading volume show traders are short/hedged and pressure can accelerate declines while sentiment shifts. (Unusual put volume reported intraday.)

About Oracle

(Get Free Report)

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.